Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents

Background and purpose: Previous studies have found that metformin can inhibit tumor growth and improve outcomes for cancer patients. However, the association between the addition of metformin to the treatment regimen and survival in non-small cell lung cancer (NSCLC) patients receiving antineoplast...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Hu, Yuanyuan, Wang, Ting, Che, Guowei, Li, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036803/
https://www.ncbi.nlm.nih.gov/pubmed/36969876
http://dx.doi.org/10.3389/fphar.2023.1123834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036803/
https://www.ncbi.nlm.nih.gov/pubmed/36969876
http://dx.doi.org/10.3389/fphar.2023.1123834

Ejemplares similares